1,3-DI-TERT-BUTYL 2-OXOPYRROLIDINE-1,3-DICARBOXYLATE, 95.0%, 1g

3-[3-(4-fluorophenoxy)phenyl]propanoic acid, 95.0%, 500mg

3-(Benzyloxy)cyclobutanecarboxylic acid, 95.0%, 250mg

2-methyltetrahydro-2H-pyrazino[1,2-a]pyrazine-1,4(3H,6H)-dione, 95.0%, 100mg

(3-(Diethylcarbamoyl)phenyl)boronic acid, 95.0%, 250mg

Sample vials ROTILABO® with short thread ND9 silanised, Brown glass, with labelling space, 1.5 ml, 100 Piece(s)

5-Chloro-6-methylnicotinonitrile, 95.0%, 1g

1-Methyl-1H-indazole-3-carbaldehyde, 95.0%, 25g

tert-Butyl 3-(4-bromo-1H-pyrazol-1-yl)pyrrolidine-1-carboxylate, 97%, 10g

METHYL 3-AMINOQUINOLINE-7-CARBOXYLATE, 95.0%, 1g

tert-Butyl 2-bromo-4-((tert-butoxycarbonyl)amino)nicotinate, 97%, 250mg

3-(1,3-Dihydro-isoindol-2-yl)-benzoic acid, 95.0%, 1g

4,6-Dichloro-2-(methylthio)pyrimidine-5-carboxylic acid, 95.0%, 25g